These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21083396)

  • 1. Sensor-augmented insulin-pump therapy in type 1 diabetes.
    Diamant M
    N Engl J Med; 2010 Nov; 363(21):2070; author reply 2071. PubMed ID: 21083396
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes.
    Bergenstal RM; Tamborlane WV; Ahmann A; Buse JB; Dailey G; Davis SN; Joyce C; Peoples T; Perkins BA; Welsh JB; Willi SM; Wood MA;
    N Engl J Med; 2010 Jul; 363(4):311-20. PubMed ID: 20587585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Insulin pump with glucose sensor in type 1 diabetes. But the artificial pancreas is still far off].
    Moberg E
    Lakartidningen; 2010 Dec 8-14; 107(49):3120-1. PubMed ID: 21284143
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of intraperitoneal insulin infusion (using implantable pump) and subcutaneous insulin administration: preliminary results of a crossover study.
    Jeandidier N; Pinget M; Keipes M; Louy S; Vetter A; Réville P
    Transplant Proc; 1992 Jun; 24(3):948-9. PubMed ID: 1604678
    [No Abstract]   [Full Text] [Related]  

  • 5. Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 diabetes; a randomized controlled trial.
    Hermanides J; Nørgaard K; Bruttomesso D; Mathieu C; Frid A; Dayan CM; Diem P; Fermon C; Wentholt IM; Hoekstra JB; DeVries JH
    Diabet Med; 2011 Oct; 28(10):1158-67. PubMed ID: 21294770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensor-augmented insulin-pump therapy in type 1 diabetes.
    Kerr D
    N Engl J Med; 2010 Nov; 363(21):2070-1; author reply 2071. PubMed ID: 21083395
    [No Abstract]   [Full Text] [Related]  

  • 7. Continuous glucose monitoring--coming of age.
    Wolpert HA
    N Engl J Med; 2010 Jul; 363(4):383-4. PubMed ID: 20587584
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessing glycaemic variability with continuous glucose monitoring system before and after continuous subcutaneous insulin infusion in people with Type 1 diabetes.
    Chimenti EM; de la Morena LH; Vaquero PM; Sáez-de-Ibarra L; Domínguez MG; Sánchez LF
    Diabetes Res Clin Pract; 2010 Dec; 90(3):e57-9. PubMed ID: 20855123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous glucose monitoring in children with type 1 diabetes: before and after insulin pump therapy.
    Heptulla RA; Allen HF; Gross TM; Reiter EO
    Pediatr Diabetes; 2004 Mar; 5(1):10-5. PubMed ID: 15043684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of use of specific features of subcutaneous insulin infusion systems and their relationship to metabolic control in patients with type 1 diabetes.
    Quirós C; Patrascioiu I; Giménez M; Vinagre I; Vidal M; Jansà M; Conget I
    Endocrinol Nutr; 2014; 61(6):318-22. PubMed ID: 24533929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metabolic control in labile type I diabetes with conventional insulin therapy, basal bolus insulin therapy using pens and continuous subcutaneous insulin infusion with the pump].
    Biesenbach G; Grafinger P; Kaiser W; Stuby U; Zazgornik J
    Med Klin (Munich); 1988 May; 83(12):398-401. PubMed ID: 3043159
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of sensor-integrated pump therapy to reduce hypoglycaemia in people with Type 1 diabetes: a real-world study in the UK.
    Choudhary P; de Portu S; Arrieta A; Castañeda J; Campbell FM
    Diabet Med; 2019 Sep; 36(9):1100-1108. PubMed ID: 31134668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metabolic control using a subcutaneous insulin infusion pump: effects 2 years after treatment].
    Goicolea Opacua I; Martínez Castillo A; Santamaría Pelarda E; Sola Sarabia C; Vázquez García JA
    Rev Clin Esp; 1988 Mar; 182(4):200-2. PubMed ID: 3045905
    [No Abstract]   [Full Text] [Related]  

  • 14. One year continuous run with a totally implantable insulin infusion pump in a human diabetic.
    Mirouze J; Selam JL; Slingeneyer A; Chaptal PA; Franetzki M; Prestele K; Mion C
    Trans Am Soc Artif Intern Organs; 1983; 29():709-13. PubMed ID: 6369734
    [No Abstract]   [Full Text] [Related]  

  • 15. [Better diabetic control with a 4-dose regime--the insulin pen makes the change easier].
    Johannsson G; Stenström G; Fahl H; Andersson AG; Fors B
    Lakartidningen; 1991 Mar; 88(11):954, 957, 959-60. PubMed ID: 2008146
    [No Abstract]   [Full Text] [Related]  

  • 16. Education on sensor-augmented pump use improves glucose control in type 1 diabetic patients.
    Thielen V; Place J; Gerbaud S; Scheen A; Bringer J; Renard E
    Diabetes Metab; 2010 Apr; 36(2):170-1. PubMed ID: 20153675
    [No Abstract]   [Full Text] [Related]  

  • 17. [Self monitoring of blood glucose: tool for successful diabetes therapy].
    Hummel M
    MMW Fortschr Med; 2012 Nov; 154(20):65-8. PubMed ID: 23234124
    [No Abstract]   [Full Text] [Related]  

  • 18. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
    Pala L; Dicembrini I; Mannucci E
    Acta Diabetol; 2019 Sep; 56(9):973-980. PubMed ID: 30945047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSII in children with diabetes.
    Hanas R
    Acta Biomed; 2005; 76 Suppl 3():36-8. PubMed ID: 16915794
    [No Abstract]   [Full Text] [Related]  

  • 20. A pilot trial in pediatrics with the sensor-augmented pump: combining real-time continuous glucose monitoring with the insulin pump.
    Halvorson M; Carpenter S; Kaiserman K; Kaufman FR
    J Pediatr; 2007 Jan; 150(1):103-105.e1. PubMed ID: 17188626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.